Invesco’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-10,861
Closed -$71K 4040
2022
Q1
$71K Buy
10,861
+93
+0.9% +$916 ﹤0.01% 3897
2021
Q4
$138K Sell
10,768
-4,406
-29% -$61.6K ﹤0.01% 3852
2021
Q3
$210K Buy
15,174
+3,773
+33% +$39.7K ﹤0.01% 3779
2021
Q2
$117K Buy
+11,401
New +$113K ﹤0.01% 3875
2019
Q2
Sell
-169,015
Closed -$1.07M 3717
2019
Q1
$1.07M Buy
169,015
+154,903
+1,098% +$1.2M ﹤0.01% 2987
2018
Q4
$91K Buy
+14,112
New +$85.5K ﹤0.01% 3660

Other funds holding APYX

Invesco's APYX Position: Q2 2022 in Review

Invesco sold out of Apyx Medical (APYX) in Q2 2022, closing a stake of 10,861 shares — an estimated $71K sold.

Invesco first reported a position in APYX in Q4 2018 and held it in 6 quarters. The position peaked at $1.07M in Q1 2019. 63 funds tracked by Wall St. Rank hold APYX as of Q2 2022.

  • Invesco reported no remaining Apyx Medical position as of Q2 2022 after selling out during the quarter.
  • Invesco sold 10,861 Apyx Medical shares in Q2 2022, an estimated $71K.
  • Invesco first reported a position in Apyx Medical in Q4 2018 and held it in 6 quarters.
  • Invesco's Apyx Medical position peaked at $1.07M in Q1 2019.
  • 63 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2022.

Based on Invesco's 13F filing for Q2 2022, filed 15 Aug 2022.